Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
6.74
+0.06 (0.90%)
At close: May 12, 2025, 4:00 PM
7.18
+0.44 (6.53%)
After-hours: May 12, 2025, 6:43 PM EDT
Bioventus Market Cap
Bioventus has a market cap or net worth of $447.25 million as of May 12, 2025. Its market cap has increased by 70.04% in one year.
Market Cap
447.25M
Enterprise Value
790.57M
1-Year Change
70.04%
Ranking
Category
Stock Price
$6.74
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $447.25M, a decrease of -37.31%. That is a compound annual growth rate of -10.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 443.27M | -35.42% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |